Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and haemodynamic monitoring, announced the results of a pivotal clinical study of high-risk surgical patients with severe aortic stenosis treated in Cohort A of The PARTNER Trial. These data demonstrate that the study achieved its primary endpoint at one year, concluding that survival of patients treated with the Edwards SAPIEN transcatheter aortic valve was equivalent to those treated with surgical aortic valve replacement. The data were presented at the American College of Cardiology’s (ACC) 60th Annual Scientific Session & Expo in New Orleans, LA, USA.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/edwardslifesciences/48895/
Invacare Corporation (NYSE:IVC), the global leader in home and long-term care medical products, today is launching “Real Life,” a new campaign dedicated to raising awareness of the everyday struggles and achievements of those living with disabilities, ailments or advancing age. For these individuals, even “ordinary” tasks like getting dressed, preparing for the day ahead, caring for children, driving a car or going to work can require extraordinary effort — yet few people are aware of these everyday struggles and achievements. Invacare has created this awareness campaign and platform so that people can share their ‘real life’ stories — or the story of someone who inspires them — for a chance to win cash prizes for themselves and the charity of their choice.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/invacare/49159/
The American Pain Foundation (APF) announced today the launch of new information and resources on pain medication safety for acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) as a part of its PainSAFE™ educational initiative. The new information will be launched with a national public service announcement (PSA) emphasizing the safe use of pain treatment options, particularly medications containing NSAIDs (aspirin, ibuprofen, naproxen) and acetaminophen (Tylenol, APAP). APF is the nation’s largest consumer advocacy organization dedicated to people with pain.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/painfoundation/49865/
Citing new evidence that many parents lack the information to prevent obesity in their children, Shape Up America! and National Turkey Federation (NTF) today announced a national mobilization to help First Lady Michelle Obama fight childhood obesity by arming parents with the facts and tools to make simple changes – or “upgrades” – in favorite meals and physical activity levels so everyone can reap the benefits of taking in less calories.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/shapeup/49869/
In honor of life, survival and a world with less breast cancer and “More Birthdays,” Kohl’s Department Stores (NYSE: KSS) threw a birthday celebration yesterday at the 2011 American Cancer Society “Making Strides Against Breast Cancer” walk on Milwaukee’s lakefront. Decorated with thousands of pink cupcakes, balloons and stacks of presents, the celebration represented the company’s greater commitment to the fight against breast cancer. In 2010, Kohl’s philanthropic program, Kohl’s Cares, announced a nearly $5 million donation over three years to the American Cancer Society’s Midwest Division.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/kohls/49599/
Medical researchers are making unprecedented progress into understanding why women suffer disproportionately from a number of diseases. Those insights are providing information to help develop medicines to attack diseases such as osteoporosis, multiple sclerosis, depression, rheumatoid arthritis and age-related macular degeneration, all of which affect more women than men.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/phrma/50270/
Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s antibacterial drug DIFICID™ (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age and older. CDAD is a significant medical problem in hospitals and long-term care facilities, and is beginning to emerge in the community among people previously at low risk for the disease. In the largest Phase 3 clinical studies ever conducted in CDAD, DIFICID had clinical response rates at the end of treatment that were non-inferior to oral vancomycin. DIFICID was superior to vancomycin in sustaining clinical response through 25 days beyond the end of treatment. DIFICID is the only FDA-approved antibacterial drug proven to be superior to vancomycin in sustained clinical response for CDAD.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/optimerpharma/50177/
With Arizona facing its share of tragedies lately – economically, politically and most recently the wildfires which have impacted thousands of residents – the community has found comfort in rallying together to celebrate the grand opening of the new Phoenix Children’s Hospital. The campus of Arizona’s only hospital 100 percent for children grew from 345 licensed beds to 465, and will ultimately house 626 licensed beds at full build-out, expected in 2013.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/phoenixchildrenshospital/50358/
Royal Philips Electronics (NYSE: PHG, AEX: PHI) today introduced the HomeLox portable liquid oxygen system. The innovative system enables oxygen users to generate and store the liquid form of oxygen in the home setting. The HomeLox system offers users the long-lasting and lightweight characteristics of traditional liquid systems, while freeing them from difficulties of filling and dependence on deliveries associated with conventional systems.
Home oxygen is a critical, life-sustaining medical treatment prescribed to nearly 1.5 million Medicare patients annually who suffer from respiratory illnesses such as chronic obstructive pulmonary disease (COPD).
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/philips/45648/
Delivering a healthy dose of good news to Midwest families, Meijer announced today that its free pre-natal vitamins prescription program has filled its 1,000,000th prescription, at a cost savings of nearly $14 million to Midwest families.
The announcement, made by Hank Meijer, Co-Chairman and CEO, came as the Midwest retailer reported that its pharmacies had hit the million-mark milestone earlier this week.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/meijer/50770/
Dendreon Corporation (Nasdaq: DNDN) announced significant milestones that support broad availability for on-label use of PROVENGE® (sipuleucel-T), the first autologous cellular immunotherapy for the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer (mCRPC).
To view Multimedia News Release, go to http://www.multivu.com/mnr/50924-dendreon-provenge-cellular-immunotherapy
Bad dietary habits and modern sedentary lifestyles have converged to create a worldwide epidemic that is constantly increasing: obesity (BMI > 30).
One billion adults around the world and twenty-two million children under the age of 5 are overweight.
Faced with this problem, LPG wanted to study the effect of LPG® mechano stimulation on fat cells to obtain proven results of the impact of Cellu M6® on localised areas of fat.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/lpg/50526/
